by Medindia Content Team on  April 23, 2006 at 12:20 PM Corporate News
Bausch & Lomb Facility under Scrutiny
Bausch & Lomb is one of the leading company which manufactures contact lens solution. But recently it was found that it caused serious eye infections in some users. After this report the Food and Drug Administration (FDA) started to inspect Bausch & Lomb facilities. There was extensive microbiological testing conducted which would take up to one month to fully analyze the culprit behind the eye infection. Bausch & Lomb stopped shipping the solution, called ReNu with MoistureLoc, and urged retailers to pull it from their shelves while officials investigated whether it contributed to cases of fungal keratitis.

It was found that the fungal infections would lead to blindness if not treated properly. The FDA said it was inspecting Bausch & Lomb facilities in Greenville, South Carolina, with the federal Centers for Disease Control and Prevention. Shares of the Rochester, New York-based company were down 18 cents at $46.82 in afternoon trading on the New York Stock Exchange. The spokesperson of the company said that a clear picture would be revealed after the testing is complete.


Most Popular on Medindia